Engaging Men From Blue-collar Industries in Weight Loss

January 30, 2024 updated by: Melissa M. Crane, PhD, Rush University Medical Center

Engaging Men From Blue-collar Industries in Weight Loss: Study 3- Evaluating the Acceptability of Weight Loss Treatments

Objectives*: Primary Objective: Aim 1: Examine the acceptability of tailored behavioral weight loss program and a standard program in men working in blue-collar occupations.

Aim 2: Compare recruitment approaches that vary on trust-based messaging to recruit men with overweight/obesity who work in blue-collar occupations.

Secondary Objectives: Determine the feasibility of retaining participants to a randomized trial over six months.

Study Overview

Detailed Description

Men working in blue-collar occupations have a high prevalence of overweight and obesity and have high rates of comorbidities associated with obesity. Unfortunately, these men are unlikely to participate in evidenced-based weight loss interventions. Further, few efficacious interventions have been developed that target this population for weight control. The purpose of this study is to test the feasibility and acceptability of tailored recruitment messages and a novel, tailored behavioral weight loss intervention in the context of a randomized trial.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Rush University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  1. Age 18 years and older
  2. Male
  3. Body mass index (BMI) > 25 kg/m2
  4. Employed >20 hours per week in an occupation classified as blue collar
  5. Ability to communicate in English
  6. Provision of signed and dated informed consent form

Exclusion criteria:

  1. History of bariatric surgery
  2. Diabetes managed with insulin
  3. Diagnosis of a serious mental illness
  4. Conditions contraindicated to exercise independently (determined using four questions of Physical Activity Readiness Questionnaire)
  5. Report of potentially hazardous alcohol use (ASSIST >27)
  6. Weight loss in the prior six months of 10 pounds or greater
  7. Body mass index ≥60 kg/m2, due to increased injury risk with exercise
  8. Diagnosis of an eating disorder
  9. Any major medical condition that could increase risk for injury or other contradictions for treatment, or high likelihood of attrition, as determined by the study team

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tailored treatment
6-months of group-based behavioral weight loss treatment tailored to men working in blue-collar occupations.
16 internet-delivered, group sessions over 6 months supported by digital handouts or videos tailored to men working in blue-collar occupations. The intervention will focus on changes to eating, physical activity, and self-monitoring.
Active Comparator: Standard of care treatment
6-months of group-based behavioral weight loss treatment following the Diabetes Prevention Program Group Lifestyle balance.
16 internet-delivered, group sessions over 6 months supported by digital handouts. The intervention will focus on changes to eating, physical activity, and self-monitoring.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction with the intervention
Time Frame: 3 months
Acceptability of the intervention will be reported as participants satisfaction with the program rated on a 7 point scale
3 months
Recruitment response
Time Frame: Baseline
Proportion of participants who enroll in study by recruitment message type
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retention rates for each intervention group
Time Frame: 6 months
Proportion of participants who complete the final follow up assessment
6 months
Recruitment reach
Time Frame: Baseline
Number of visits to study websites
Baseline
Participant satisfaction with the intervention
Time Frame: 6 months
Acceptability of the intervention will be reported as participants satisfaction with the program rated on a 7 point scale
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinically significant weight loss
Time Frame: Baseline, 3, and 6 months
Proportion of participants who achieve a weight loss >5% of initial weight
Baseline, 3, and 6 months
Program perceptions
Time Frame: 3 and 6 months
Semi-structured interviews to evaluate participants perceptions of program
3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melissa M Crane, PhD, Rush University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 31, 2022

Primary Completion (Actual)

November 15, 2023

Study Completion (Actual)

November 15, 2023

Study Registration Dates

First Submitted

May 12, 2022

First Submitted That Met QC Criteria

May 17, 2022

First Posted (Actual)

May 23, 2022

Study Record Updates

Last Update Posted (Estimated)

February 1, 2024

Last Update Submitted That Met QC Criteria

January 30, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18013105-IRB01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Tailored behavioral weight loss program

3
Subscribe